Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors.

Curr Opin Pulm Med. 26: 527-534Sikjær M.G. Hilberg O. Ibsen R. et al.

Sarcoidosis: A nationwide registry-based study of incidence, prevalence and diagnostic work-up.

Respir Med. 187: 106548Rybicki B.A. Major M. Popovich J. et al.

Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization.

Am J Epidemiol. 145: 234-241Arkema E.V. Grunewald J. Kullberg S. et al.

Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden.

Eur Respir J. 48: 1690-1699Drent M. Crouser E.D. Grunewald J.

Challenges of Sarcoidosis and Its Management.

N Engl J Med. 385: 1018-1032Valeyre D. Prasse A. Nunes H. et al.

Sarcoidosis.

Lancet. 383: 1155-1167Rossi G. Cavazza A. Colby T.V.

Pathology of Sarcoidosis.

Clin Rev Allergy Immunol. 49: 36-44

Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex?.

Am J Respir Cell Mol Biol. 27: 391-395Grunewald J. Spagnolo P. Wahlström J. et al.

Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Clin Rev Allergy Immunol. 49: 19-35Agostini C. Adami F. Semenzato G.

New pathogenetic insights into the sarcoid granuloma.

Curr Opin Rheumatol. : 1271-1276Spagnolo P. Rossi G. Trisolini R. et al.

Pulmonary sarcoidosis.

Lancet Respir Med. 6: 389-402Terwiel M. van Moorsel C.H.M.

Clinical epidemiology of familial sarcoidosis: A systematic literature review.

Respir Med. 149: 36-41

Genetics in sarcoidosis.

Curr Opin Pulm Med. 27: 423-429Rossman M.D. Thompson B. Frederick M. et al.

HLA-DRB1∗1101: a significant risk factor for sarcoidosis in blacks and whites.

Am J Hum Genet. 73: 720-735Berlin M. Fogdell-Hahn A. Olerup O. et al.

HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.

Am J Respir Crit Care Med. 156: 1601-1605Spagnolo P. Renzoni E.A. Wells A.U. et al.

C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome.

Am J Respir Crit Care Med. 168: 1162-1166Valentonyte R. Hampe J. Huse K. et al.

Sarcoidosis is associated with a truncating splice site mutation in BTNL2.

Nat Genet. 37: 357-364Hofmann S. Franke A. Fischer A. et al.

Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis.

Nat Genet. 40: 1103-1106

Etiologies of Sarcoidosis.

Clin Rev Allergy Immunol. 49: 6-18Drake W.P. Pei Z. Pride D.T. et al.

Molecular analysis of sarcoidosis tissues for mycobacterium species DNA.

Emerg Infect Dis. 8: 1334-1341Chen E.S. Wahlström J. Song Z. et al.

T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

J Immunol. 181: 8784-8796Song Z. Marzilli L. Greenlee B.M. et al.

Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis.

J Exp Med. 201: 755-767

Pathology of sarcoidosis.

Semin Respir Crit Care Med. 28: 36-52Izbicki G. Chavko R. Banauch G.I. et al.

World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City Fire Department rescue workers.

Chest. 131: 1414-1423Crouser E.D. Maier L.A. Wilson K.C. et al.

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline.

Am J Respir Crit Care Med. 201: e26-e51Bernardinello N. Petrarulo S. Balestro E. et al.

Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis.

Diagnostics. 11: 1558Costabel U. Bonella F. Ohshimo S. et al.

Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET.

Semin Respir Crit Care Med. 31: 404-408Agarwal R. Srinivasan A. Aggarwal A.N. et al.

Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: A systematic review and meta-analysis.

Resp Med. 106: 883-892

Sex-specific manifestations of Löfgren's syndrome.

Am J Respir Crit Care Med. 175: 40-44

Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation.

Br Med J. 2: 1165-1172Spagnolo P. Sverzellati N. Wells A.U. et al.

Imaging aspects of the diagnosis of sarcoidosis.

Eur Radiol. 24: 807-816Criado E. Sánchez M. Ramírez J. et al.

Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation.

Radiographics. 30: 1567-1586Gupta R. Judson M.A. Baughman R.P.

Management of Advanced Pulmonary Sarcoidosis.

Am J Respir Crit Care Med. 205: 495-506Mañá J. Rubio-Rivas M. Villalba N. et al.

Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain.

Medicine (Baltim). 96: e7595Inoue Y. Inui N. Hashimoto D. et al.

Cumulative incidence and predictors of progression in corticosteroid- naıve patients with sarcoidosis.

PLoS One. 10: e0143371Valeyre D. Jeny F. Rotenberg C. et al.

How to Tackle the Diagnosis and Treatment in the Diverse Scenarios of Extrapulmonary Sarcoidosis.

Adv Ther. 38: 4605-4627Haimovic A. Sanchez M. Judson M.A. et al.

Sarcoidosis: a comprehensive review and update for the dermatologist, part I: Cutaneous disease.

J Am Acad Dermatol. 66: 699.e1-18Wu J.H. Imadojemu S. Caplan A.S.

The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Am J Clin Dermatol. 23: 499-514Sève P. Jamilloux Y. Tilikete C. et al.

Ocular Sarcoidosis.

Semin Respir Crit Care Med. 41: 673-688

Ocular sarcoidosis.

Int Ophthalmol Clin. 55: 15-24Birnie D.H. Nery P.B. Ha A.C. et al.

Cardiac sarcoidosis.

J Am Coll Cardiol. 68: 411-421Iwai K. Sekiguti M. Hosoda Y. et al.

Racial difference in cardiac sarcoidosis incidence observed at autopsy.

Sarcoidosis. 11: 26-31

The Many Faces of Cardiac Sarcoidosis.

Am J Clin Pathol. 153: 294-302Trivieri M.G. Spagnolo P. Birnie D. et al.

Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.

J Am Coll Cardiol. 76: 1878-1901Joubert B. Chapelon-Abric C. Biard L. et al.

Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis.

JAMA Neurol. 74: 1336-1344Fritz D. van de Beek D. Brouwer M.C.

Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis.

BMC Neurol. 16: 220Bradshaw M.J. Pawate S. Koth L.L. et al.

Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment.

Neurol Neuroimmunol Neuroinflamm. 8: e1084Tadros M. Forouhar F. Wu G.Y.

Hepatic Sarcoidosis.

J Clin Transl Hepatol. 1: 87-93Ungprasert P. Crowson C.S. Simonetto D.A. et al.

Clinical Characteristics and Outcome of Hepatic Sarcoidosis: A Population-Based Study 1976-2013.

Am J Gastroenterol. 112: 1556-1563

Extrapulmonary sarcoidosis.

Semin Respir Crit Care Med. 28: 83-101

Renal sarcoidosis: approach to diagnosis and management.

Curr Opin Pulm Med. 24: 513-520de Kleijn W.P. De Vries J. Lower E.E. et al.

Fatigue in sarcoidosis: a systematic review.

Curr Opin Pulm Med. 15: 499-506Hoitsma E. Marziniak M. Faber C.G. et al.

Small fiber neuropathy in sarcoidosis.

Lancet. 359: 2085-2086Tavee J.O. Karwa K. Ahmed Z. et al.

Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment.

Respir Med. 126: 135-138Heij L. Dahan A. Hoitsma E. Sarcoidosis and pain caused by Small-fiber neuropathy. 2012. Pain Res Treat, : 256024Baughman R.P. Valeyre D. Korsten P. et al.

ERS clinical practice guidelines on treatment of sarcoidosis.

Eur Respir J. 58: 2004079Gibson G.J. Prescott R.J. Muers M.F. et al.

British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment.

Thorax. 51: 238-247Ungprasert P. Ryu J.H. Matteson E.L.

Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis.

Mayo Clin Proc Innov Qual Outcomes. 3: 358-375

Lung transplantation for pulmonary sarcoidosis.

Sarcoidosis Vasc Diffuse Lung Dis. 36: 92-107Pasadhika S. Rosenbaum J.T.

Ocular Sarcoidosis.

Clin Chest Med. 36: 669-683Sadek M.M. Yung D. Birnie D.H. et al.

Corticosteroid therapy for cardiac sarcoidosis: a systematic review.

Can J Cardiol. 29: 1034-1041Krause M.L. Cooper L.T. Chareonthaitawee P. et al.

Successful use of rituximab in refractory cardiac sarcoidosis.

Rheumatology. 55: 189-191Jackson K.C. Youmans Q.R. Wu T. et al.

Heart transplantation outcomes in cardiac sarcoidosis.

J Heart Lung Transplant. 41: 113-122Ungprasert P. Matteson E.L. Neurosarcoidosis. Rheum Dis Clin North Am. 43: 593-606

Neurosarcoidosis: clinical manifestations, diagnosis and treatment.

Presse Med. 41: e331-e348Cohen Aubart F. Bouvry D. Galanaud D. et al.

Long-term outcomes of refractory neurosarcoidosis treated with infliximab.

J Neurol. 264: 891-897Judson M.A. Boan A.D. Lackland D.T.

The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States.

Sarcoidosis Vasc Diffuse Lung Dis. 29: 119-127Swigris J.J. Olson A.L. Huie T.J. et al.

Sarcoidosis-related mortality in the United States from 1988 to 2007.

Am J Respir Crit Care Med. 183: 1524-1530